Your browser doesn't support javascript.
loading
Targeting interleukin-10 signalling for cancer immunotherapy, a promising and complicated task.
Ni, Guoying; Zhang, Lu; Yang, Xiaodan; Li, Hejie; Ma, Bowei; Walton, Shelley; Wu, Xiaolian; Yuan, Jianwei; Wang, Tianfang; Liu, Xiaosong.
Afiliación
  • Ni G; Department of Nuclear Medicine, The First Affiliated Hospital/School of Clinical Medicine of Guangdong Pharmaceutical University , Guangzhou, China.
  • Zhang L; Genecology Research Centre, University of the Sunshine Coast , Maroochydore, Australia.
  • Yang X; School of Medical Science, Griffith Health Institute, Griffith University , Gold Coast, Australia.
  • Li H; Department of Nuclear Medicine, The First Affiliated Hospital/School of Clinical Medicine of Guangdong Pharmaceutical University , Guangzhou, China.
  • Ma B; Department of Nuclear Medicine, The First Affiliated Hospital/School of Clinical Medicine of Guangdong Pharmaceutical University , Guangzhou, China.
  • Walton S; Genecology Research Centre, University of the Sunshine Coast , Maroochydore, Australia.
  • Wu X; Institute of Industrial Science, Department of Mechanical and Bio-functional System, The University of Tokyo , Tokyo, Japan.
  • Yuan J; Department of Nuclear Medicine, The First Affiliated Hospital/School of Clinical Medicine of Guangdong Pharmaceutical University , Guangzhou, China.
  • Wang T; Genecology Research Centre, University of the Sunshine Coast , Maroochydore, Australia.
  • Liu X; Cancer Research Institute, First People's Hospital of Foshan , Foshan, Guangdong, China.
Hum Vaccin Immunother ; 16(10): 2328-2332, 2020 10 02.
Article en En | MEDLINE | ID: mdl-32159421

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Interleucina-10 / Neoplasias Límite: Humans Idioma: En Revista: Hum Vaccin Immunother Año: 2020 Tipo del documento: Article País de afiliación: China

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Interleucina-10 / Neoplasias Límite: Humans Idioma: En Revista: Hum Vaccin Immunother Año: 2020 Tipo del documento: Article País de afiliación: China